Price is only modestly above the pivot (98.47) and still below nearby resistance (103.16), so upside looks limited near-term unless it cleanly breaks >103.
If you must act today (no waiting): HOLD / avoid initiating until price reclaims 103+ with strength; otherwise risk/reward is not compelling at ~100 pre-market.
Technical Analysis
Trend/Momentum: MACD histogram -0.693 (below zero) but negatively contracting → selling pressure may be easing, yet trend isn’t bullish.
RSI(6): 50.48 (neutral) → no strong momentum edge.
Moving averages: converging → range-bound / indecision rather than a clean trend.
Key levels: Pivot 98.47 (current pre-mkt ~100.31 slightly above), Resistance R1 103.16 then R2 106.06; Support S1 93.78 then S2 90.88.
Pattern-based forward odds: modest bias higher (approx. +0.41% 1W, +1.35% 1M) but not strong enough to override sentiment headwinds.
Event risk: next earnings 2026-03-05 pre-market (can dominate technicals into the print).
Options Data
Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning/Sentiment: Put/Call is elevated on both open interest (1.69) and volume (2.49) → market is skewed defensive/bearish (or heavily hedged).
Volatility: 30D IV 74.5 vs HV 34.6 with IV percentile 78 / IV rank 63 → options are priced rich, implying the market expects sizable moves (often around catalysts).
Flow activity: today’s volume ~103% of 30D avg and OI also ~103% of avg → active participation, but directionality favors puts.
Technical Summary
Sell
8
Buy
3
Positive Catalysts
keeps a near-term rebound path open toward 103–106 if buyers show up.
Neutral/Negative Catalysts
Insiders are selling aggressively (selling amount up 14866.51% over the last month) → notable near-term confidence overhang.
Options market is defensive (high put/call on OI and volume) → sentiment leans bearish/hedged.
Latest reported quarter showed profitability pressure (net income, EPS, and gross margin down YoY) despite revenue growth.
Near resistance overhead (103 area): failure to break can keep the stock trapped in a range and frustrate impatient entries.
Financial Performance
Latest quarter provided: 2026/Q3.
Revenue: $1.2906B, +6.75% YoY (top-line still growing).
Net income: $113.0M, -14.38% YoY (earnings quality weakened vs last year).
EPS:2.36, -5.60% YoY.
Gross margin:62.52%, -3.95% YoY → margin compression is the key negative trend.
Takeaway: growth is present, but profit/margin trends are going the wrong way into the next earnings cycle.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is more bullish overall: multiple firms raised targets and several have Buy ratings.
Citi (2026-01-21): upgraded to Buy from Neutral; PT $135 (from $90) citing favorable risk/reward and FY26 FCF strength.
UBS (2026-01-08):Buy, PT $160 (from $130) on consumer resilience and multi-year earnings momentum.
Barclays/Morgan Stanley: more balanced (Equal Weight) with raised PTs.
Wall Street pros vs cons: Pros = brand positioning + cash flow + continued sales momentum; Cons = margin/earnings pressure and valuation/sentiment risk reflected by defensive options and insider selling.
Wall Street analysts forecast ANF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANF is 115.25 USD with a low forecast of 90 USD and a high forecast of 160 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast ANF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANF is 115.25 USD with a low forecast of 90 USD and a high forecast of 160 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 99.100
Low
90
Averages
115.25
High
160
Current: 99.100
Low
90
Averages
115.25
High
160
Citi
Neutral -> Buy
upgrade
$90 -> $135
AI Analysis
2026-01-21
Reason
Citi
Price Target
$90 -> $135
AI Analysis
2026-01-21
upgrade
Neutral -> Buy
Reason
Citi upgraded Abercrombie & Fitch to Buy from Neutral with a price target of $135, up from $90.
Citi
Neutral -> Buy
upgrade
$90 -> $135
2026-01-21
Reason
Citi
Price Target
$90 -> $135
2026-01-21
upgrade
Neutral -> Buy
Reason
Citi upgraded Abercrombie & Fitch to Buy from Neutral with a price target of $135, up from $90. The firm views the 17% selloff post the company's preliminary results as unwarranted. Abercrombie's two brands are well positioned for growth in fiscal 2026, the analyst tells investors in a research note. Citi sees a favorable risk/reward post the pullback, saying Abercrombie will post strong free cash flow in fiscal 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ANF
